Cognitive Outcomes Following Intravitreal Bevacizumab for Retinopathy of Prematurity: 4- to 6-Year Outcomes in a Prospective Cohort.
Chou Hung-Da, Shih Chia-Pang, Huang Yu-Shu, +5 more·American journal of ophthalmology
PURPOSE: To determine the long-term cognitive outcomes in children who underwent intravitreal bevacizumab (IVB) for retinopathy of prematurity (ROP). DESIGN: Prospective cohort study. METHODS: This single-center study enrolled 186 children between 3 and 6 years of age and included 101 children in the final analysis:…